1
|
Zhou C, He S, Liu D, Zuo Y, Chen Q, Wang L, Chen B, Chen F, Luo J, Xu X, Lin L. Reference intervals for erythrocyte parameters and hemoglobin electrophoresis parameters for young children in Guangxi. Int J Lab Hematol 2023; 45:104-111. [PMID: 36064301 DOI: 10.1111/ijlh.13965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Accepted: 08/11/2022] [Indexed: 01/18/2023]
Abstract
BACKGROUND Erythrocyte parameter analysis is the important means for diagnosis and treatment of hematological diseases, which are essential for screening of thalassemia in southern China combined with hemoglobin electrophoresis analysis. But little is known regarding the reference intervals (RIs) in healthy pediatrics in these two areas. METHODS 95% RIs of erythrocyte parameters were calculated from 853 healthy preschoolers, aged from 1 days to <6 years, according to the C28-A3C guidelines of the Institute of Clinical and Laboratory Standards. To express the magnitude of sex and age variation, standard deviation ratio (SDR) was calculated using ANOVA. Concurrently, we selected 3814 thalassemia carriers as carriers group and drew receiver operating characteristic (ROC) curves to establish the optimal cut-off values of hemoglobin electrophoresis parameters, which were used as the upper/lower limits of RIs to efficiently screen thalassemia. RESULTS All parameters except red blood cell (RBC) required age partitioning, confirmed by SDRage above .4. There was no need for sex partitioning on all parameters, confirmed by SDRsex below .4. The optimal cut-off value of Hemoglobin A2 (Hb A2) in the four subgroups was <7.8% (Hb A), 2.3%-3.2%, 2.5%-3.6% and 2.6%-3.6%, respectively. CONCLUSION In this study, the establishment of RIs improved the diagnostic efficiency of hematological disease (especially thalassaemia) for children in Guangxi. It provides reliable hematological references for the identification and diagnosis, treatment monitoring, and health screening of children's clinical diseases.
Collapse
Affiliation(s)
- Chaofan Zhou
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Sheng He
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Dun Liu
- Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China
| | - Yangjin Zuo
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Qiuli Chen
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Liang Wang
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Biyan Chen
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Faqin Chen
- Youjiang Medical University for Nationalities, Baise, Guangxi, People's Republic of China
| | - Jingsi Luo
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Xiangmin Xu
- Department of Medical Genetics, School of Basic Medical Sciences and Southern Medical University, Guangzhou, Guangdong, People's Republic of China
| | - Li Lin
- Genetic and Metabolic Central Laboratory, Birth Defects Prevention and Control Institute, Reproductive Health and Birth Defects Prevention, Guangxi Clinical Research Center for Pediatric Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| |
Collapse
|